Close

Immunomedics (IMMU) Misses Q1 EPS by 3c

November 3, 2016 7:30 AM EDT

Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $129.2 thousand versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings